{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:28:34Z","timestamp":1790706514807,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Physiology & Neurobiology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.resp.2014.10.018","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T08:06:56Z","timestamp":1415174816000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Pro- and antiangiogenic markers in patients with pulmonary complications of systemic scleroderma"],"prefix":"10.1016","volume":"209","author":[{"given":"E.","family":"G\u0142odkowska-Mr\u00f3wka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"G\u00f3rska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ciurzy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stelmaszczyk-Emmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bienias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Irzyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Siwicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lipi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Ciepiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pruszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Demkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resp.2014.10.018_bib0005","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/art.22698","article-title":"Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis","volume":"56","author":"Cipriani","year":"2007","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.resp.2014.10.018_bib0010","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/art.22698","article-title":"Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis","volume":"56","author":"Cipriani","year":"2007","journal-title":"Arthritis. Rheum."},{"key":"10.1016\/j.resp.2014.10.018_bib0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.autrev.2011.04.016","article-title":"Cellular players in angiogenesis during the course of systemic sclerosis","volume":"10","author":"Cipriani","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.resp.2014.10.018_bib0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10067-013-2354-8","article-title":"Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis","volume":"33","author":"Ciurzynski","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.resp.2014.10.018_bib0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.humpath.2005.10.007","article-title":"The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis","volume":"37","author":"Davies","year":"2006","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.resp.2014.10.018_bib0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: a potent inhibitor of angiogenesis","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.resp.2014.10.018_bib0035","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm870","article-title":"Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas","volume":"9","author":"Doll","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.resp.2014.10.018_bib0040","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11926-009-0015-3","article-title":"Is scleroderma a vasculopathy?","volume":"11","author":"Fleming","year":"2009","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.resp.2014.10.018_bib0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1476-4598-13-89","article-title":"TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF\/PEDF signaling","volume":"13","author":"Fu","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.resp.2014.10.018_bib0050","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Galie","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.resp.2014.10.018_bib0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.trsl.2007.12.010","article-title":"Identification of candidate genes in scleroderma-related pulmonary arterial hypertension","volume":"151","author":"Grigoryev","year":"2008","journal-title":"Transl. Res."},{"key":"10.1016\/j.resp.2014.10.018_bib0060","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.autrev.2006.12.006","article-title":"Vascular complications of scleroderma","volume":"6","author":"Guiducci","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.resp.2014.10.018_bib0065","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.2353\/ajpath.2010.091085","article-title":"Pigment epithelium-derived factor is an intrinsic antifibrosis factor targeting hepatic stellate cells","volume":"177","author":"Ho","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.resp.2014.10.018_bib0070","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.resp.2014.10.018_bib0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-94-007-4549-0_19","article-title":"Antiendothelial cells antibodies in patients with systemic sclerosis in relation to pulmonary hypertension and lung fibrosis","volume":"756","author":"Lewandowska","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.resp.2014.10.018_bib0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tcm.2012.05.011","article-title":"Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant","volume":"21","author":"Manetti","year":"2011","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.resp.2014.10.018_bib0085","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/bjo.2008.156810","article-title":"Plasma levels of vascular endothelial growth factor and pigment epithelium-derived factor before and after intravitreal injection of bevacizumab","volume":"94","author":"Matsuyama","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.resp.2014.10.018_bib0090","doi-asserted-by":"crossref","first-page":"45400","DOI":"10.1074\/jbc.M208339200","article-title":"Mapping the type I collagen-binding site on pigment epithelium-derived factor. Implications for its antiangiogenic activity","volume":"277","author":"Meyer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.resp.2014.10.018_bib0095","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0006-291X(03)00446-7","article-title":"Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells","volume":"303","author":"Ohno-Matsui","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.resp.2014.10.018_bib0100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2466-9-18","article-title":"Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis","volume":"9","author":"Papaioannou","year":"2009","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.resp.2014.10.018_bib0105","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj20030313","article-title":"Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization","volume":"374","author":"Petersen","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.resp.2014.10.018_bib0110","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1167\/iovs.10-6254","article-title":"Nicotine increases the VEGF\/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD","volume":"52","author":"Pons","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.resp.2014.10.018_bib0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-011-0219-1","article-title":"Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts","volume":"14","author":"Rabquer","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.resp.2014.10.018_bib0120","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/ajg.2010.479","article-title":"Pigment epithelium-derived factor associates with neuropathy and fibrosis in pancreatic cancer","volume":"106","author":"Samkharadze","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.resp.2014.10.018_bib0125","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1016\/j.ajpath.2011.08.009","article-title":"Pigment epithelium-derived factor regulates early pancreatic fibrotic responses and suppresses the profibrotic cytokine thrombospondin-1","volume":"179","author":"Schmitz","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.resp.2014.10.018_bib0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cbi.2014.04.020","article-title":"Andrographolide inhibits tumor angiogenesis via blocking VEGFA\/VEGFR2-MAPKs signaling cascade","volume":"218","author":"Shen","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.resp.2014.10.018_bib0135","doi-asserted-by":"crossref","first-page":"e43898","DOI":"10.1371\/journal.pone.0043898","article-title":"Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating alpha7AChR, ERK, HIF-1alpha and VEGF\/PEDF signaling","volume":"7","author":"Shi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.resp.2014.10.018_bib0140","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1016\/j.lfs.2005.05.048","article-title":"Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells","volume":"77","author":"Takenaka","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.resp.2014.10.018_bib0145","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ajpath.2010.10.018","article-title":"Administration of pigment epithelium-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction","volume":"178","author":"Ueda","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.resp.2014.10.018_bib0150","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 Classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.resp.2014.10.018_bib0155","doi-asserted-by":"crossref","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","article-title":"Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor","volume":"269","author":"Waltenberger","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.resp.2014.10.018_bib0160","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2337\/db05-1448","article-title":"Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities","volume":"55","author":"Wang","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.resp.2014.10.018_bib0165","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1167\/iovs.08-2878","article-title":"Antipermeability function of PEDF involves blockade of the MAP kinase\/GSK\/beta-catenin signaling pathway and uPAR expression","volume":"51","author":"Yang","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"Suppl. 6","key":"10.1016\/j.resp.2014.10.018_bib0170","first-page":"791","article-title":"Angiogenic activity of sera from patients with systemic autoimmune diseases in relation to clinical, radiological, and functional pulmonary status","volume":"59","author":"Zielonka","year":"2008","journal-title":"J. Physiol. Pharmacol."}],"container-title":["Respiratory Physiology & Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904814002900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904814002900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:34:56Z","timestamp":1761604496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569904814002900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":34,"alternative-id":["S1569904814002900"],"URL":"https:\/\/doi.org\/10.1016\/j.resp.2014.10.018","relation":{},"ISSN":["1569-9048"],"issn-type":[{"value":"1569-9048","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro- and antiangiogenic markers in patients with pulmonary complications of systemic scleroderma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Physiology & Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resp.2014.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}